Persistence of DNA adducts, hypermutation and acquisition of cellular resistance to alkylating agents in glioblastoma.

about

Persistence of DNA adducts, hypermutation and acquisition of cellular resistance to alkylating agents in glioblastoma.

Item

http://www.wikidata.org/entity/Q48024213

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Persistence of DNA adducts, hy ...... lating agents in glioblastoma.

@en

Persistence of DNA adducts, hy ...... lating agents in glioblastoma.

@nl

type

Item

label

Persistence of DNA adducts, hy ...... lating agents in glioblastoma.

@en

Persistence of DNA adducts, hy ...... lating agents in glioblastoma.

@nl

prefLabel

Persistence of DNA adducts, hy ...... lating agents in glioblastoma.

@en

Persistence of DNA adducts, hy ...... lating agents in glioblastoma.

@nl

P1476

Persistence of DNA adducts, hy ...... ylating agents in glioblastoma

@en

P2093

D Rundle-Thiele

http://www.w3.org/2001/XMLSchema#string

J H Martin

http://www.w3.org/2001/XMLSchema#string

K Y C Fung

http://www.w3.org/2001/XMLSchema#string

L Cosgrove

http://www.w3.org/2001/XMLSchema#string

M F Fay

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

DNA repair mechanisms and their clinical impact in glioblastoma

Deficient mismatch repair: Read all about it (Review)

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression

P304

917-926

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15384047.2017.1385680

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Richard Head

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29020502

http://www.w3.org/2001/XMLSchema#string

P932

5718815

http://www.w3.org/2001/XMLSchema#string